Pekarskaya, Elizabeth A.
Holt, Emma S.
Gingrich, Jay A.
Ansorge, Mark S.
Javitch, Jonathan A.
Canetta, Sarah E.
Funding for this research was provided by:
Hope for Depression Research Foundation
Brain and Behavior Research Foundation (26089)
National Institute for Mental Health (K01MH107760)
Article History
Received: 2 June 2021
Accepted: 14 October 2021
First Online: 24 November 2021
Competing interests
: Dr. Javitch is a cofounder of Kures Inc. and a co-inventor on patents held by Columbia University on tianeptine analogs licensed to Kures. All other authors declare no competing interests.